How can MRD and disease be assessed in routine practice?
Clinical implications of persisting preleukemic clones in remission in acute myeloid leukemia (AML)
Germline predispositions in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Jane E. Churpek
How to treat a previously treated CLL patient
Predict response to immune checkpoint inhibition in acute myeloid leukemia (AML) using biomarkers
Naval G. Daver